Annexin A1: A new immunohistological marker of cholangiocarcinoma

World Journal of Gastroenterology

Volumn 19, Issue 16, 2013, Pages 2456-2465

  Hongsrichan, Nuttanan ^a   Rucksaken, Rucksak ^a   Chamgramol, Yaovalux ^a   Pinlaor, Porntip ^a   Techasen, Anchalee ^a   Yongvanit, Puangrat ^a   Khuntikeo, Narong ^a   Pairojkul, Chawalit ^a   Pinlaor, Somchai ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Annexin A1; Biomarker; Cholangiocarcinoma; Hepatocellular carcinoma; Opisthorchis viverrini

Indexed keywords

GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 1; MESSENGER RNA; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SILENCING; HAMSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER HISTOLOGY; MALE; NONHUMAN; OPISTHORCHIASIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR GROWTH; WESTERN BLOTTING;

EID: 84877260823     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i16.2456     Document Type: Article

References (36)

1. Kamsa-ard S, Wiangnon S, Suwanrungruang K, Promthet S, Khuntikeo N, Kamsa-ard S, Mahaweerawat S. Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholangiocarcinoma. Asian Pac J Cancer Prev 2011; 12: 2209-2213 [PMID: 22296358]
2. Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Wiangnon S, Sripa B, Hong ST. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 2010; 101: 579-585 [PMID: 20085587 DOI: 10.1111/j.13497006.2009.01458.x]
3. Sripa B, Bethony JM, Sithithaworn P, Kaewkes S, Mairiang E, Loukas A, Mulvenna J, Laha T, Hotez PJ, Brindley PJ. Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop 2011; 120 Suppl 1: S158-S168 [PMID: 20655862 DOI: 10.1016/j.actatropica.2010.07.006]
4. Khan SA, Emadossadaty S, Ladep NG, Thomas HC, Elliott P, Taylor-Robinson SD, Toledano MB. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol 2012; 56: 848-854 [PMID: 22173164 DOI: 10.1016/j.jhep.2011.11.015]
5. Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin DM. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health 2004; 9: 588-594 [PMID: 15117303 DOI: 10.1111/j.1365-3156.2004.01234.x]
6. Sripa B, Pairojkul C. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 2008; 24: 349-356 [PMID: 18408464 DOI: 10.1097/MOG.0b013e3282fbf9b3]
7. Patel T. Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol 2011; 8: 189-200 [PMID: 21460876 DOI: 10.1038/nrgastro.2011.20]
8. Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007; 13: 1505-1515 [PMID: 17461441]
9. Khuntikeo N, Pugkhem A, Bhudhisawasdi V, Uttaravichien T. Major hepatic resection for hilar cholangiocarcinoma without preoperative biliary drainage. Asian Pac J Cancer Prev 2008; 9: 83-85 [PMID: 18439081]
10. Nakajima T, Kondo Y. Well-differentiated cholangiocarci-noma: diagnostic significance of morphologic and immunohistochemical parameters. Am J Surg Pathol 1989; 13: 569-573 [PMID: 2544115]
11. Jovanovic R, Jagirdar J, Thung SN, Paronetto F. Blood-group-related antigen Lewis(x) and Lewis(y) in the differential diagnosis of cholangiocarcinoma and hepatocellular carcinoma. Arch Pathol Lab Med 1989; 113: 139-142 [PMID: 2537068]
12. Ganjei P, Nadji M, Albores-Saavedra J, Morales AR. Histologic markers in primary and metastatic tumors of the liver. Cancer 1988; 62: 1994-1998 [PMID: 2458825]
13. Sampatanukul P, Leong AS, Kosolbhand P, Tangkijvanich P. Proliferating ductules are a diagnostic discriminator for intrahepatic cholangiocarcinoma in FNA biopsies. Diagn Cytopathol 2000; 22: 359-363 [PMID: 10820529]
14. Rullier A, Le Bail B, Fawaz R, Blanc JF, Saric J, Bioulac-Sage P. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 2000; 24: 870-876 [PMID: 10843291]
15. Kakar S, Gown AM, Goodman ZD, Ferrell LD. Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms. Arch Pathol Lab Med 2007; 131: 1648-1654 [PMID: 17979482]
16. Yongvanit P, Pinlaor S, Bartsch H. Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. Parasitol Int 2012; 61: 130-135 [PMID: 21704729 DOI: 10.1016/j.parint.2011.06.011]
17. Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, Perretti M, Nusrat A. Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 2006; 281: 19588-19599 [PMID: 16675446 DOI: 10.1074/ jbc.M513025200]
18. Wang AG, Yoon SY, Oh JH, Jeon YJ, Kim M, Kim JM, Byun SS, Yang JO, Kim JH, Kim DG, Yeom YI, Yoo HS, Kim YS, Kim NS. Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags. Biochem Biophys Res Commun 2006; 345: 1022-1032 [PMID: 16712791 DOI: 10.1016/j.bbrc. 2006.04.175]
19. Wang D, Zhang H, Fang Z, Yu G. Annexin-1 downregulation is associated with clinical outcome in Chinese patients with hilar cholangiocarcinoma. Eur Surg Res 2010; 45: 151-157 [PMID: 20924191 DOI: 10.1159/000320237]
20. de Coupade C, Gillet R, Bennoun M, Briand P, Russo-Marie F, Solito E. Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology 2000; 31: 371-380 [PMID: 10655260 DOI: 10.1002/ hep.510310217]
21. Masaki T, Tokuda M, Ohnishi M, Watanabe S, Fujimura T, Miyamoto K, Itano T, Matsui H, Arima K, Shirai M, Maeba T, Sogawa K, Konishi R, Taniguchi K, Hatanaka Y, Hatase O, Nishioka M. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology 1996; 24: 72-81 [PMID: 8707286 DOI: 10.1002/hep.510240114]
22. Xue LY, Teng LH, Zou SM, Ren LQ, Zheng S, Luo W, Bi R, Lü N. [Expression of annexin I in different histological types of carcinomas]. Zhonghua Zhongliu Zazhi 2007; 29: 444-448 [PMID: 17974280]
23. Prakobwong S, Yongvanit P, Hiraku Y, Pairojkul C, Sithithaworn P, Pinlaor P, Pinlaor S. Involvement of MMP-9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1-dependent DNA damage in a hamster model. Int J Cancer 2010; 127: 2576-2587 [PMID: 20162672 DOI: 10.1002/ijc.25266]
24. Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 2009; 9: 62-70 [PMID: 19104500 DOI: 10.1038/nri2470]
25. Bizzarro V, Petrella A, Parente L. Annexin A1: novel roles in skeletal muscle biology. J Cell Physiol 2012; 227: 3007-3015 [PMID: 22213240 DOI: 10.1002/jcp.24032]
26. Sato Y, Kumamoto K, Saito K, Okayama H, Hayase S, Kofunato Y, Miyamoto K, Nakamura I, Ohki S, Koyama Y, Takenoshita S. Up-regulated Annexin A1 expression in gastrointestinal cancer is associated with cancer invasion and lymph node metastasis. Exp Ther Med 2011; 2: 239-243 [PMID: 22977491 DOI: 10.3892/etm.2011.210]
27. Ouyang N, Zhu C, Zhou D, Nie T, Go MF, Richards RJ, Rigas B. MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitis. PLoS One 2012; 7: e41585 [PMID: 22844504 DOI: 10.1371/journal.pone.0041585]
28. Kang H, Ko J, Jang SW. The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells. Biochem Biophys Res Commun 2012; 423: 188-194 [PMID: 22640735 DOI: 10.1016/j.bbrc.2012.05.114]
29. de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, Kartopawiro J, Pardali E, Le Dévédec SE, Smit VT, van der Wal A, Van't Veer LJ, Cleton-Jansen AM, ten Dijke P, van de Water B. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci United States 2010; 107: 6340-6345 [PMID: 20308542 DOI: 10.1073/pnas.0913360107]
30. Wiercinska E, Naber HP, Pardali E, van der Pluijm G, van Dam H, ten Dijke P. The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system. Breast Cancer Res Treat 2011; 128: 657-666 [PMID: 20821046 DOI: 10.1007/s10549-010-1147-x]
31. Perretti M, Dalli J. Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br J Pharmacol 2009; 158: 936-946 [PMID: 19845684 DOI: 10.1111/j.1476-5381.2009.00483.x]
32. Li CF, Shen KH, Huang LC, Huang HY, Wang YH, Wu TF. Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma. Pathology 2010; 42: 43-49 [PMID: 20025479 DOI: 10.3109/00313020903434405]
33. Vong L, Ferraz JG, Dufton N, Panaccione R, Beck PL, Sherman PM, Perretti M, Wallace JL. Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis. PLoS One 2012; 7: e39244 [PMID: 22723974 DOI: 10.1371/journal.pone.0039244]
34. Oliani SM, Ciocca GA, Pimentel TA, Damazo AS, Gibbs L, Perretti M. Fluctuation of annexin-A1 positive mast cells in chronic granulomatous inflammation. Inflamm Res 2008; 57: 450-456 [PMID: 18827967 DOI: 10.1007/s00011-008-7222-7]
35. Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hof-stetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CT. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 2006; 12: 4598-4604 [PMID: 16899607 DOI: 10.1158/1078-0432.CCR-06-0483]
36. Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, Chia D, Seligson D, Chang HR, Goodglick L. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 2006; 37: 1583-1591 [PMID: 16949910 DOI: 10.1016/j.humpath.2006.06.001]